Proven, Not Just Promised: The SkinSync® Testing Standards

At SkinSync®, quality is not assumed — it is verified. Every batch is independently tested to confirm purity, potency, and label accuracy, giving customers confidence in a product built on documented standards rather than unsupported claims. Independent analysis verifies key product details, including active ingredient levels and the absence of unwanted contaminants. For customers, that means clear reassurance that what is listed on the label is what has been confirmed through testing.

Our Testing Framework

Our testing process reflects the extreme care behind every patch.

• Accredited Labs: very production run is assessed by independent, appropriately certified third-party laboratories, including facilities operating to recognised standards such as GLP, NATA, and ISO/IEC 17025.
• Batch Sampling: We take multiple samples across each batch to ensure absolute consistency from start to finish.
• Total Transparency: Independent analysis verifies key product details, active ingredient levels, and the complete absence of unwanted contaminants.

Batch Testing Process

Every production run undergoes a rigorous, multi-stage analysis using ISO/IEC 17025-aligned methods.

• Uniformity Checks: Samples are collected from the beginning, middle, and end of each batch to verify uniform distribution across the entire production run.
• Full Screening: Testing covers identity, quantity, contaminants, and stability.
• Traceability: All lab results are permanently archived for full traceability.

Purity and Potency Verification

We utilise advanced scientific methods like HPLC (High-Performance Liquid Chromatography) and GC-MS (Gas Chromatography-Mass Spectrometry) to measure active ingredients.

• Label Declarations: Testing confirms ingredients perfectly match label declarations.
• Precise Dosage: For SkinSync®, this includes verifying exactly 15 mg of CBD isolate per patch within an acceptable variance range.
• Safety Screening: Testing checks for contaminants, microbes, and other cannabinoids to ensure total consistency from batch to batch.

THC-Free Confirmation

We place a strict emphasis on THC-free confirmation and traceable documentation.

• Targeted Screening: We use LC-MS (Liquid Chromatography-Mass Spectrometry) to confirm undetectable THC levels.
• Verified Expectations: This provides added confidence that the final product aligns perfectly with THC-free expectations.
• Certificates of Analysis: Every finding is officially documented in a Certificate of Analysis (COA) for each lot and is available upon request.

Dermatological safety:

SkinSync®’s hypoallergenic safety profile is supported by Human Repeat Insult Patch Test (HRIPT) studies conducted on human subjects through ISO/IEC 17025:2017 certified independent laboratories. These studies help confirm that our formulas meet strict dermatological safety standards, demonstrating that they are non-irritating, non-sensitising, and suitable for regular topical use on the skin.

Key Testing Metrics

Documentation and Access

Certificates of Analysis are maintained for every lot, supporting accountable manufacturing, retailer and consumer confidence, and full traceability from production through to shelf. They are available on the website (see Certificate of Analysis Page).

What This Means Practically

For customers, this testing framework provides practical reassurance: each patch is supported by verified active content, documented quality standards, and clear traceability. Rather than relying on marketing claims alone, SkinSync® uses independent third-party testing to prioritise safety, accuracy, and consistency. In a growing wellness category where trust matters, this gives customers greater confidence to make informed choices and incorporate SkinSync® into regular wellness routines.

Questions on specific results? Contact support@skinsyncpatches.com.